The COVID-19 Infectious Disease team at University Health System andUT Health San Antonio has launched the second stage of a clinical trial involving a coronavirus drug that has delivered promising results.

Thomas Patterson, M.D., a professor in the Long School of Medicine and chief of the Division of Infectious Diseases at UT Health San Antonio, is leading the study at University Hospital.

Read and watch the full story.

The post KSAT 12: University Hospital, UT Health San Antonio begin second phase of patient testing for promising COVID-19 drug appeared first on UT Health San Antonio.